Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
27.83
+1.22 (4.58%)
Feb 2, 2026, 4:00 PM EST - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.33 billion as of February 3, 2026. Its market cap has increased by 171.84% in one year.
Market Cap
1.33B
Enterprise Value
821.44M
1-Year Change
171.84%
Ranking
Category
Stock Price
$27.83
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.33B, an increase of 120.55%. That is a compound annual growth rate of 61.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.27B | -12.29% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 1.42B |
| AtaiBeckley | 1.42B |
| Novavax | 1.40B |
| Pharming Group | 1.39B |
| Trevi Therapeutics | 1.39B |
| AnaptysBio | 1.37B |
| Relay Therapeutics | 1.35B |
| DBV Technologies | 1.33B |